Value of 111In-DOTA-lanreotide and 111In-DOTA-DPhe1-Tyr3-octreotide in differentiated thyroid cancer. In-vitro and in-vivo studies. Comparison with 18F-FDG-PET.

M. Rodrigues; Tatjana Traub; M. Leimer; S. Li; Frank Andreas; Peter Angelberger; Robert Dudczak; Irene Virgolini

Value of 111In-DOTA-lanreotide and 111In-DOTA-DPhe1-Tyr3-octreotide in differentiated thyroid cancer. In-vitro and in-vivo studies. Comparison with 18F-FDG-PET.

M. Rodrigues
, Tatjana Traub
, M. Leimer
, S. Li
, Frank Andreas
, Peter Angelberger
, Robert Dudczak
, Irene Virgolini

Medical University of Vienna
University of Natural Resources and Life Sciences Vienna (BOKU)

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1144-1151
Number of pages	8
Journal	European Journal of Nuclear Medicine and Molecular Imaging
Publication status	Published - 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research Field

Biosensor Technologies

Keywords

111In-DOTA-lanreotide

Cite this

@article{168bab41780143138f9c8121ee166c8a,

title = "Value of 111In-DOTA-lanreotide and 111In-DOTA-DPhe1-Tyr3-octreotide in differentiated thyroid cancer. In-vitro and in-vivo studies. Comparison with 18F-FDG-PET.",

keywords = "111In-DOTA-lanreotide, 111In-DOTA-lanreotide",

author = "M. Rodrigues and Tatjana Traub and M. Leimer and S. Li and Frank Andreas and Peter Angelberger and Robert Dudczak and Irene Virgolini",

year = "2005",

language = "English",

pages = "1144--1151",

journal = "European Journal of Nuclear Medicine and Molecular Imaging",

issn = "1619-7070",

publisher = "Springer",

}

TY - JOUR

T1 - Value of 111In-DOTA-lanreotide and 111In-DOTA-DPhe1-Tyr3-octreotide in differentiated thyroid cancer. In-vitro and in-vivo studies. Comparison with 18F-FDG-PET.

AU - Rodrigues, M.

AU - Traub, Tatjana

AU - Leimer, M.

AU - Li, S.

AU - Andreas, Frank

AU - Angelberger, Peter

AU - Dudczak, Robert

AU - Virgolini, Irene

PY - 2005

Y1 - 2005

KW - 111In-DOTA-lanreotide

M3 - Article

SN - 1619-7070

SP - 1144

EP - 1151

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

ER -